Clinical Trials
3
Active:0
Completed:2
Trial Phases
1 Phases
Phase 3:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 3
3 (100.0%)HRN 004- Peginterferon a-2a Plus Ribavirin for Chronic Hepatitis C Infection in HIV Infected Persons Who Have Failed to Achieve a Sustained Virologic Response Following Previous Interferon Therapy
Phase 3
- Conditions
- HIV InfectionsChronic Hepatitis C Infection in HIV Infected Persons
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2005-10-25
- Lead Sponsor
- Hepatitis Resource Network
- Registration Number
- NCT00215839
- Locations
- 🇺🇸
Mt. Sinai School of Medicine, New York, New York, United States
PEG-Interferon a-2b + Ribavirin for Treatment of Chronic HRN 005 Hepatitis C Infection in HIV-Infected Persons Not Previously Treated With Interferon
Phase 3
Completed
- Conditions
- Chronic Hepatitis C Infection in HIV-Infected PersonsHIV Infections
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2005-10-25
- Lead Sponsor
- Hepatitis Resource Network
- Target Recruit Count
- 300
- Registration Number
- NCT00215891
- Locations
- 🇺🇸
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
PEG-Interferon a-2b + Ribavirin for Treatment of Patients With Chronic Hepatitis C Who Have Previously Failed to Achieve a Sustained Virologic Response Following Interferon Alfa or Interferon a-2b + Ribavirin Therapy
Phase 3
Completed
- Conditions
- Chronic Hepatitis C Virus Infection
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2005-09-22
- Lead Sponsor
- Hepatitis Resource Network
- Target Recruit Count
- 600
- Registration Number
- NCT00215865
- Locations
- 🇺🇸
Johns Hopkins Univesity School of Medicine, Baltimore, Maryland, United States
News
No news found